Skip to Content

G 0522 G 0522 (Fenofibrate (Micronized) 134 mg)

Pill with imprint G 0522 G 0522 is White, Capsule-shape and has been identified as Fenofibrate (Micronized) 134 mg. It is supplied by Global Pharmaceuticals.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 0522 G 0522

Fenofibrate (micronized) 134 mg G 0522 G 0522
Fenofibrate (micronized) 134 mg G 0522 G 0522
Fenofibrate (micronized) 134 mg G 0522 G 0522 Front
Fenofibrate (micronized) 134 mg G 0522 G 0522 Back
Fenofibrate (micronized) 134 mg G 0522 G 0522

Fenofibrate (Micronized)

Imprint
G 0522 G 0522
Strength
134 mg
Color
White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Global Pharmaceuticals
Inactive Ingredients
croscarmellose sodium, hypromellose 2910 (6 mPa.s), magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, gelatin, titanium dioxide, shellac, ferrosoferric oxide, propylene glycol, FD&C Blue No. 2, FD&C Red No. 40, D&C Yellow No. 10, aluminum oxide, FD&C Blue No. 1

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00115-0522 Global Pharmaceuticals
68084-0835 Amerisource Health Services
54868-5994 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "G 0522 G 0522"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.